The DeSci Podcast

Democratizing Early-Stage Research Funding: Inside Catalyst, Molecule’s DeSci Funding Machine

Aug 19, 2024
Benji Leibowitz, a biotech expert with a focus on computational biology, and Kevin Noessler, a tech-savvy product innovator, dive into the groundbreaking Catalyst platform. They tackle the limitations of traditional research funding and the notorious 'Valley of Death' that stifles innovation. With talk of decentralized funding through NFTs and the importance of equitable intellectual property access, they explore how Catalyst is reshaping the future of scientific research. The conversation highlights dynamic pricing strategies and the potential for blockchain to foster collaboration in biotech.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Benji's Journey to Molecule

  • Benji Leibowitz shares his journey from biotech research to Molecule, motivated by the intersection of crypto and biotech for incentive alignment.
  • He highlights the lack of patient value in traditional data monetization and the potential of NFTs for democratizing biotech IP.
INSIGHT

Understanding the Valley of Death

  • The "Valley of Death" in drug development is the funding gap between government grants and venture capital.
  • Decentralized science aims to fill this critical underfunded gap to help early-stage research progress.
INSIGHT

Science Incentives Limit Sharing

  • Current science systems discourage sharing half-baked ideas due to incentive structures favoring complete stories.
  • Decentralized incentives could unlock collaborative research, overcoming existing motivation barriers.
Get the Snipd Podcast app to discover more snips from this episode
Get the app